• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致糖基化先天性疾病Ia型(CDG-Ia)的磷酸甘露糖变位酶2(PMM2)突变。

Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

作者信息

Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, Kjaergaard S, Martinsson T, Schwartz M, Seta N, Vuillaumier-Barrot S, Westphal V, Winchester B

机构信息

Center for Human Genetics, University of Leuven, Leuven, Belgium.

出版信息

Hum Mutat. 2000 Nov;16(5):386-94. doi: 10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y.

DOI:10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y
PMID:11058895
Abstract

The PMM2 gene, which is defective in CDG-Ia, was cloned three years ago [Matthijs et al., 1997b]. Several publications list PMM2 mutations [Matthijs et al., 1997b, 1998; Kjaergaard et al., 1998, 1999; Bjursell et al., 1998, 2000; Imtiaz et al., 2000] and a few mutations have appeared in case reports or abstracts [Crosby et al., 1999; Kondo et al., 1999; Krasnewich et al., 1999; Mizugishi et al., 1999; Vuillaumier-Barrot et al., 1999, 2000b]. However, the number of molecularly characterized cases is steadily increasing and many new mutations may never make it to the literature. Therefore, we decided to collate data from six research and diagnostic laboratories that have committed themselves to a systematic search for PMM2 mutations. In total we list 58 different mutations found in 249 patients from 23 countries. We have also collected demographic data and registered the number of deceased patients. The documentation of the genotype-phenotype correlation is certainly valuable, but is out of the scope of this molecular update. The list of mutations will also be available online (URL: http://www.kuleuven. ac.be/med/cdg) and investigators are invited to submit new data to this PMM2 mutation database.

摘要

在先天性糖基化障碍I型(CDG-Ia)中存在缺陷的磷酸甘露糖变位酶2(PMM2)基因于三年前被克隆出来[马蒂伊斯等人,1997b]。有几篇出版物列出了PMM2突变[马蒂伊斯等人,1997b,1998;克亚尔加德等人,1998,1999;比尤塞尔等人,1998,2000;伊姆蒂亚兹等人,2000],并且在病例报告或摘要中出现了一些突变[克罗斯比等人,1999;近藤等人,1999;克拉斯纽维奇等人,1999;水岸等人,1999;维约米耶-巴罗等人,1999,2000b]。然而,分子特征明确的病例数量在稳步增加,许多新突变可能永远不会出现在文献中。因此,我们决定整理来自六个致力于系统搜索PMM2突变的研究和诊断实验室的数据。我们总共列出了在来自23个国家的249名患者中发现的58种不同突变。我们还收集了人口统计学数据并记录了死亡患者的数量。基因型-表型相关性的记录当然很有价值,但超出了本次分子更新的范围。突变列表也将在网上公布(网址:http://www.kuleuven. ac.be/med/cdg),并邀请研究人员向这个PMM2突变数据库提交新数据。

相似文献

1
Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).导致糖基化先天性疾病Ia型(CDG-Ia)的磷酸甘露糖变位酶2(PMM2)突变。
Hum Mutat. 2000 Nov;16(5):386-94. doi: 10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y.
2
PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.在以斯堪的纳维亚家庭为重点的大量1A型先天性糖基化障碍(CDG)家系材料中,PMM2基因突变谱,包括10种新突变。
Hum Mutat. 2000 Nov;16(5):395-400. doi: 10.1002/1098-1004(200011)16:5<395::AID-HUMU3>3.0.CO;2-T.
3
Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.两名先天性糖基化障碍I型(CDG-Ia)患者中两种罕见的PMM2截短突变的特征分析
Mol Genet Metab. 2007 Apr;90(4):408-13. doi: 10.1016/j.ymgme.2007.01.003. Epub 2007 Feb 16.
4
Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).先天性糖基化代谢异常Ia型(CDG-Ia)中最常见的PMM2突变不符合哈迪-温伯格平衡。
Eur J Hum Genet. 2000 May;8(5):367-71. doi: 10.1038/sj.ejhg.5200470.
5
PMM2 intronic branch-site mutations in CDG-Ia.先天性糖基化代谢异常I型a(CDG-Ia)中的磷酸甘露糖变位酶2(PMM2)内含子分支点突变
Mol Genet Metab. 2006 Apr;87(4):337-40. doi: 10.1016/j.ymgme.2005.10.015. Epub 2005 Dec 20.
6
Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.碳水化合物缺乏糖蛋白综合征Ia型中415G>A(E139K)PMM2突变的特征:该突变破坏了一个剪接增强子,导致外显子5跳跃。
Hum Mutat. 1999 Dec;14(6):543-4. doi: 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S.
7
Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.I型先天性糖基化障碍:探寻PMM2常见突变的起源
Ann Hum Genet. 2007 May;71(Pt 3):348-53. doi: 10.1111/j.1469-1809.2006.00334.x. Epub 2006 Dec 12.
8
Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.在PMM2基因中鉴定出的三种剪接突变的功能分析:迈向先天性糖基化代谢异常Ia型的新疗法
Hum Mutat. 2009 May;30(5):795-803. doi: 10.1002/humu.20960.
9
Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.由于传递比率失真,先天性糖基化障碍Ia型(CDG-Ia)的复发风险增加。
J Med Genet. 2004 Nov;41(11):877-80. doi: 10.1136/jmg.2004.022350.
10
Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.Ia型先天性糖基化障碍:1例患有小脑病变的新生儿的临床病理报告
Acta Neuropathol. 2005 Apr;109(4):433-42. doi: 10.1007/s00401-004-0975-3. Epub 2005 Feb 16.

引用本文的文献

1
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG.在一种新型的PMM2-CDG小鼠模型中,基于腺相关病毒的基因替代疗法可预防并阻止异常神经表型的显现。
Gene Ther. 2025 May;32(3):246-254. doi: 10.1038/s41434-025-00525-w. Epub 2025 Mar 17.
2
A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.一种补体 C4 衍生的糖肽是 PMM2-CDG 的生物标志物。
JCI Insight. 2024 Apr 8;9(7):e172509. doi: 10.1172/jci.insight.172509.
3
-CDG T237M Mutation in a Patient with Cerebral Palsy-Like Phenotypes Reported from South India.
- 来自印度南部的一名具有脑瘫样表型患者的先天性糖基化障碍T237M突变
Glob Med Genet. 2023 Jun 1;10(2):105-108. doi: 10.1055/s-0043-1769494. eCollection 2023 Jun.
4
Hemostatic defects in congenital disorders of glycosylation.先天性糖基化障碍中的止血缺陷。
Res Pract Thromb Haemost. 2023 Mar 30;7(3):100142. doi: 10.1016/j.rpth.2023.100142. eCollection 2023 Mar.
5
Phosphomannomutase 2 hyperinsulinemia: Recent advances of genetic pathogenesis, diagnosis, and management.磷酸甘露糖变位酶 2 型高胰岛素血症:遗传发病机制、诊断和治疗的最新进展。
Front Endocrinol (Lausanne). 2023 Jan 16;13:1102307. doi: 10.3389/fendo.2022.1102307. eCollection 2022.
6
Hyperinsulinemic Hypoglycemia Due to Mutation in Two Siblings with Autosomal Recessive Polycystic Kidney Disease.两名患有常染色体隐性多囊肾病的兄弟姐妹因基因突变导致高胰岛素血症性低血糖症。
Pediatr Rep. 2022 Oct 24;14(4):444-449. doi: 10.3390/pediatric14040052.
7
A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report.PMM2-CDG 由与杂合 70 千碱基缺失相关的 A108V 突变引起的病例报告。
Ital J Pediatr. 2022 Oct 11;48(1):178. doi: 10.1186/s13052-022-01355-x.
8
Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency.磷酸甘露糖变位酶 2 缺乏症伴低血糖患者的高胰岛素血症可能报道不足。
J Clin Res Pediatr Endocrinol. 2022 Aug 25;14(3):275-286. doi: 10.4274/jcrpe.galenos.2022.2021-10-14. Epub 2022 Mar 21.
9
Genotype-Phenotype Correlations in PMM2-CDG.PMM2-CDG 中的基因型-表型相关性。
Genes (Basel). 2021 Oct 21;12(11):1658. doi: 10.3390/genes12111658.
10
Non-functional alternative splicing caused by a Latino pathogenic variant in a case of PMM2-CDG.PMM2-CDG病例中由拉丁裔致病变体引起的无功能选择性剪接。
Mol Genet Metab Rep. 2021 Jul 2;28:100781. doi: 10.1016/j.ymgmr.2021.100781. eCollection 2021 Sep.